AlphaYouKH
Congress trade
Rep. Kevin Hern (R-OK) bought $1K-$15K of Johnson & Johnson (JNJ) stock
Kevin Hern, U.S. Representative (R-OK), disclosed a purchase of Johnson & Johnson (JNJ) stock worth $1K-$15K in a STOCK Act filing on Jul 15, 2022.
The trade happened on Jun 7, 2022, 38 days before it was made public.
JNJ has moved +43.6% since the trade date, from $178.34 to $256.03 (Oct 2, 2026 close).
- Traded
- Jun 7, 2022
- Disclosed
- Jul 15, 2022
- Filing delay
- 38 days
- Price since
- +43.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (16)
- SellCERN$15K-$50KJul 15, 2022
- BuyDVN$15K-$50KJul 15, 2022
- BuyPXD$15K-$50KJul 15, 2022
- BuyAGCO$1K-$15KJul 15, 2022
- BuyDVN$1K-$15KJul 15, 2022
- BuyEMR$1K-$15KJul 15, 2022
- BuyHD$1K-$15KJul 15, 2022
- BuyINTC$1K-$15KJul 15, 2022
- BuyLMT$1K-$15KJul 15, 2022
- BuyMSFT$1K-$15KJul 15, 2022
- BuyNEE$1K-$15KJul 15, 2022
- BuyPXD$1K-$15KJul 15, 2022
- BuyROK$1K-$15KJul 15, 2022
- BuyRTX$1K-$15KJul 15, 2022
- BuyWMB$1K-$15KJul 15, 2022
- BuyXOM$1K-$15KJul 15, 2022
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.